SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001520138-24-000086
Filing Date
2024-03-04
Accepted
2024-03-04 07:50:52
Documents
19
Period of Report
2024-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT bivi-20240304_8k.htm   iXBRL 8-K 33189
2 EXHIBIT 4.1 bivi-20240304_8kex4z1.htm EX-4.1 101161
3 EXHIBIT 4.2 bivi-20240304_8kex4z2.htm EX-4.2 92357
4 EXHIBIT 10.1 bivi-20240304_8kex10z1.htm EX-10.1 392637
5 EXHIBIT 99.1 bivi-20240304_8kex99z1.htm EX-99.1 11646
6 EXHIBIT 99.2 bivi-20240304_8kex99z2.htm EX-99.2 10665
  Complete submission text file 0001520138-24-000086.txt   976630

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE bivi-20240304.xsd EX-101.SCH 3027
8 XBRL LABEL FILE bivi-20240304_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE bivi-20240304_pre.xml EX-101.PRE 22367
20 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20240304_8k_htm.xml XML 3612
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 24712869
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)